Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.

So what’s next for Xavier Becerra? According to Becerra allies, who requested anonymity to discuss his plans candidly, he is “strongly considering” running for governor and is already ...

In a wide-ranging interview, Xavier Becerra, President Biden’s health secretary, defended his tenure and hinted that he might ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

CMS had until Feb. 1 to announce the new batch of drugs chosen ... Health and Human Services Secretary Xavier Becerra called the announcement a “great way to close out the four-year term of the ...

The CMS said that the 23.6 million sign-ups to ... not over yet," Department of Health and Human Services Secretary Xavier Becerra said in the release. "The Affordable Care Act health insurance ...

The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has selected 15 additional drugs for pr ...

BECERRA’S FINAL ACT — During the unveiling of his official portrait on Tuesday, HHS Secretary Xavier Becerra ... is returning as CMS chief operating officer. — Drew Snyder is expected ...

Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...

As they entered office at the height of the coronavirus pandemic in early 2021, Xavier Becerra and his allies had a plan to restore Americans’ faith in the nation’s beleaguered public health ...

Secretary of Health and Human Services Xavier Becerra tours the Long Beach Public Health Department and hosts a roundtable on pandemic preparedness on June 1, 2023. (Luis Sinco / Los Angeles Times) ...

The Centers for Medicare and Medicaid Services (CMS) released its second round of drug negotiation targets, a list of 15 drugs under Medicare Part D, including Novo Nordisk's (NVO) blockbuster GLP-1s.